Corcept Therapeutics | CORT - 流动负债



金融业
股票价格
USD
资产
USD 814.88M
现金及等价物
USD 108.74M
销售成本
USD 2.88M
流动资产
USD 426.03M
流动负债
USD 149.19M
债务
USD 6.11M
EBIT
USD -49.6M
EBITDA
USD 4.2M
员工
500
EPS每股收益
USD -0.3
股本和储备
USD 637.99M
销售毛利
USD 162.02M
债务利息支出
USD 814.88M
利息收入
USD 5.42M
市值
USD 8.5B
净收入
USD -31.76M
营业费用
USD 214.5M
营业利润
USD -49.6M
普通股股本
USD 107.33M
PE价格收益
113.58
税前利润
USD 9.91M
销售收入
USD 164.9M
销售和管理费用
USD 128.04M
股票
USD 12.89M
贸易债权人
USD 33.31M
应收帐款人
USD 39.07M


流动负债 更改 日
Acadia Pharmaceuticals USD 305.52M 28.41M 2026-03
Alaunos Therapeutics USD 595K 218K 2026-03
ANI Pharmaceuticals USD 239.51M 38.6M 2026-03
Ardelyx USD 109.57M 20.96M 2026-03
Assertio Holdings USD 166.78M 34.25M 2025-09
Aurora Cannabis CAD 145.94M 21.82M 2025-12
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Canopy Growth CAD 98.29M 17.19M 2025-12
Corcept Therapeutics USD 149.18M 16.9M 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Esperion Therapeutics USD 300.36M 451K 2026-03
J&J USD 57.72B 3.59B 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Lexicon Pharmaceuticals USD 9.9M 10.97M 2026-03
Merck USD 26.94B 1.38B 2026-03
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novartis USD 31.37B 4.1B 2026-03
Novartis USD 27.28B 4.72B 2025-12
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 108.79M 11.8M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Supernus Pharmaceuticals USD 373.93M 35.76M 2026-03
TG Therapeutics USD 187.11M 33.35M 2026-03